3D Printing of Poloxamer 407 Nanogel Discs and Their Applications in Adjuvant Ovarian Cancer Therapy

Mol Pharm. 2019 Feb 4;16(2):552-560. doi: 10.1021/acs.molpharmaceut.8b00836. Epub 2019 Jan 16.

Abstract

Nanogels are attractive biocompatible materials that enable local delivery of multiple drugs. In this study, we demonstrated that 3D printing technology could be used to precisely construct nanogel discs carrying paclitaxel and rapamycin. 3D-printed nanogel disc rounds (12 mm diameter × 1 mm thickness) carrying paclitaxel and rapamycin evaded premature gelation during storage and the initial burst release of the drugs in the dissolution medium. In vivo 3D-printed nanogel discs permitted successful intraperitoneal delivery of paclitaxel and rapamycin in ES-2-luc ovarian-cancer-bearing xenograft mice. They were also shown to be therapeutically effective and capable of preventing postsurgical peritoneal adhesions in the treated xenograft mice.

Keywords: 3D printing; ovarian cancer; paclitaxel; peritoneal adhesion; poloxamer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / therapeutic use
  • Female
  • Humans
  • Mice
  • Ovarian Neoplasms / drug therapy*
  • Paclitaxel / therapeutic use
  • Poloxamer / chemistry*
  • Printing, Three-Dimensional*
  • Sirolimus / therapeutic use
  • Xenograft Model Antitumor Assays

Substances

  • Antibiotics, Antineoplastic
  • Poloxamer
  • Paclitaxel
  • Sirolimus